As of April 19, 2025, Context Therapeutics (CNTX) has a market cap of $75.630 million USD. According to our data, Context Therapeutics is ranked No.7786 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 19, 2025 | $75.63 M |
-3.96%
|
Dec 31, 2024 | $78.75 M |
-7.08%
|
Dec 29, 2023 | $84.75 M |
73.31%
|
Dec 30, 2022 | $48.90 M |
-75.49%
|
Dec 31, 2021 | $0.20 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Gilead Sciences
GILD
|
$130.32 B |
-0.001 M
|
![]() USA
|
![]() Amgen
AMGN
|
$149.09 B |
0.124 B
|
![]() USA
|
![]() Biogen
BIIB
|
$17.36 B |
-0.001 M
|
![]() USA
|
![]() Regeneron Pharmaceuticals
REGN
|
$61.57 B |
1.023 B
|
![]() USA
|
![]() Moderna
MRNA
|
$9.56 B |
-0.000 M
|
![]() USA
|
![]() BioMarin Pharmaceutical
BMRN
|
$11.35 B |
0.000 M
|
![]() USA
|
![]() Incyte
INCY
|
$11.27 B |
0.000 M
|
![]() USA
|
![]() Alnylam Pharmaceuticals
ALNY
|
$30.36 B |
0.000 M
|
![]() USA
|
![]() Ionis Pharmaceuticals
IONS
|
$4.51 B |
-0.000 M
|
![]() USA
|
![]() Sarepta Therapeutics
SRPT
|
$5.22 B |
0.000 M
|
![]() USA
|
![]() Blueprint Medicines
BPMC
|
$5.41 B |
0.000 M
|
![]() USA
|
![]() Ultragenyx
RARE
|
$3.35 B |
0.000 M
|
![]() USA
|
![]() CRISPR Therapeutics
CRSP
|
$3.26 B |
0.000 M
|
![]() Switzerland
|
Market Cap | = | CNTX Stock Price | * | CNTX Shares Outstanding |
= | $0.84 | * | 89.70 M | |
= | $75.63 M |